Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 2017 Aug;63(8):596.

Correction

PMCID: PMC5555323  PMID: 28807951

In the article “Community-associated methicillin-resistant Staphylococcus aureus infection,” which appeared in the July issue of Canadian Family Physician,1 an error was inadvertently introduced in Table 2. The correct version of the table appears below.

Table 2.

Treatment of outpatient SSTI in the era of CA-MRSA

SSTI TREATMENT
Simple cutaneous abscess (in a low-risk patient not involving face, hands, or genitalia) Incision and drainage alone; obtain culture
Purulent cellulitis (without abscess): treat for CA-MRSA if risk factors present Tetracycline, trimethoprim-sulfamethoxazole, or clindamycin
Nonpurulent cellulitis (no exudate): treat for β-hemolytic streptococcus β-Lactam antibiotic (cloxacillin or first-generation cephalosporin)

CA-MRSA—community-associated methicillin-resistant Staphylococcus aureus, SSTI—skin and soft tissue infection.

*

A detailed management algorithm is available within the Infectious Diseases Society of America guidelines 2014 update on SSTIs.74 All recommendations are level II evidence, adapted from the Infectious Diseases Society of America 2011 guidelines.65

Canadian Family Physician apologizes for this error and any confusion it might have caused.

Reference

  • 1.Loewen K, Schreiber Y, Kirlew M, Bocking N, Kelly L. Community-associated methicillin-resistant Staphylococcus aureus infection. Literature review and clinical update. Can Fam Physician. 2017;63:512–20. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES